Study Identifies Protein Biomarkers of Prostate Cancer
Measuring serum autoantibodies in a liquid biopsy of prostate cancer patients, researchers successfully confirmed tissue-specific biomarkers via immunohistochemistry.
Read MoreSearch Results for: prostate cancer
GenomeDx Launches Genomic Test for Prostate Cancer
The launch brings the Decipher prostate cancer classifier, already clinically adopted and extensively validated for use following surgery, to newly diagnosed patients at initial biopsy.
Read MoreAnalysis of Prostate Cancer Biopsies Validated to Predict Metastasis
GenomeDx Biosciences recently presented first validation data supporting the use of its Decipher test to help guide the treatment of men newly diagnosed with prostate cancer.
Read MoreMetamark, Hologic Collaborate on Prostate Cancer
The Progensa prostate cancer antigen 3 assay can help improve prediction of repeat biopsy outcomes in men who have had one or more prior negative prostate biopsies.
Read More
Study of Decipher Prostate Cancer Test Selected for 2015 Best of ASTRO
The Decipher genomic test for the prediction of cancer recurrence following prostate surgery and radiation was featured at the annual meeting of the American Society for Therapeutic Radiology and Oncology.
Read More